PMO Interview with the Innovator Series: Volume 1
Video Categories: PMO Interview with the Innovator Series
Deborah Dunsire, MD, President and CEO of Millennium: The Takeda Oncology Company, and Kathy Giusti, Founder and CEO of the Multiple Myeloma Research Foundation, discuss the issues and vision in improving personalized medicine strategies for patients with multiple myeloma.
Deborah Dunsire, MD, is the former President and CEO of Millennium Pharmaceuticals, Inc.
Jayson Slotnik provides an overview of the issues in demonstrating the value of personalized medicine tests and products
David S. Siegel, MD, PhD, at the John Theurer Cancer Center in Hackensack, NJ, explains the benefits of worldwide clinical trials in creating more consistent, less toxic treatment options for multiple myeloma. New drugs are coming along, and the clinical trials for those drugs are beginning to mature.